Esomeprazole Magnesium
Product Images NDC 45865-892

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 45865-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsourcer Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (892)

Pdp (892)
This is a description of Esomeprazole Magnesium generic capsules of 20mg, which is a substitute for NexilM. The manufacturer is Aurbindo Pharma Ltd and the product is identified by the code 45365089230 S. The rest of the text is not available.*
FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Fig1)

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Fig1)
The figure shows the maintenance of healing rates by month in Study 178, represented in percentages for four different treatments: Esomeprazole Magnesium 40 mg, 20 mg, and 10 mg, as well as a placebo. The x-axis represents scheduled visits.*
FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Fig2)

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Fig2)
The text shows a figure labeled as "Figure 2" which displays the maintenance of healing rates by month in Study 1. The graph has a Y-axis labeled as "Percent Maintained" with values ranging from 0 to 100. The X-axis shows the number of months ranging from 0 to 65. The graph compares the effect of Esomeprazole Magnesium at different dosages (10mg, 20mg, and 40mg) versus placebo. The figure suggests that higher dosages of the medication have a greater impact on maintaining healing rates over time.*
FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)
FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)
FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical Structure (Esomeprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.